FMR LLC

Position in AVTX — Avalo Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in AVTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$94,251,990

+$51,261,339 QoQ

Shares Held

5,100,216

+77.1% QoQ

Ownership

9.51%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 126 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,667,384 across 370 Biotechnology names. AVTX ranks #98 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-07-31	$104,717,879	5,737,966	+12.5%	Shares	Sole	2026-08-07
2026-06-30	$94,251,990	5,100,216	+77.1%	Shares	Defined	2026-08-13
2026-06-30	$94,251,991	5,100,216	—	Shares	Sole	2026-08-06
2026-03-31	$42,990,651	2,879,481	+1207.1%	Shares	Defined	2026-05-15
2025-12-31	$4,000,648	220,300	+22029900.0%	Shares	Defined	2026-02-17
2024-09-30	$9	1	-50.0%	Shares	Defined	2024-11-13
2024-06-30	$24	2	-84.6%	Shares	Defined	2024-08-13
2022-12-31	$65	13	-62.9%	Shares	Defined	2023-02-13
2022-09-30	$116	35	-97.1%	Shares	Defined	2022-11-10
2022-06-30	$609	1,220	+390.0%	Shares	Defined	2022-08-12
2022-03-31	$180	249	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.